Patient-reported symptom and urgent healthcare use in neuroendocrine tumors
ESAS scores are associated with subsequent short-term urgent healthcare use after NET diagnosis. This indicates a potential gap in managing outpatient patient-reported symptoms. Routine monitoring of ESAS scores could be leveraged to identify patients at high risk of urgent healthcare use in need for better symptom management.
Authors
- Christopher W. Noel (ORCID: https://orcid.org/0000-0002-6625-0809)
- Julie Hallet (ORCID: https://orcid.org/0000-0001-5108-1072)
- Simron Jit Singh (ORCID: https://orcid.org/0000-0001-7012-893X)
- Sten Myrehaug (ORCID: https://orcid.org/0000-0002-5765-1969)
- Carlos H.F. Chan (ORCID: https://orcid.org/0000-0003-3656-2470)
- Natalie Coburn
- Anna Gombay
- Rinku Sutradhar
- Katrina Duncan
- Antoine Eskander
- Calvin Law
Institutions
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Sunnybrook Research Institute
Publication Details
- Journal
- Endocrine Oncology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1530/eo-25-0050
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00